文献速递药物相互作用

氨茶碱联合安立生坦在缺氧环境下的安全性与运动增强特性

Safety and Ergogenic Properties of Combined Aminophylline and Ambrisentan in Hypoxia.
PubMed 文献 · Clin Pharmacol Ther · 2017-10-17

本研究在常氧志愿者中确立氨茶碱(500 mg)联合安立生坦(5 mg)的安全性与药物相互作用,随后在模拟海拔4,267 m的健康静息及运动志愿者中开展安慰剂对照研究。结果显示无严重不良事件,药物相互作用极小或不存在,联合用药不依赖提高血氧 availability 而改善缺氧运动能力。

要点

  • 氨茶碱500 mg联合安立生坦5 mg在常氧志愿者中安全,药物相互作用极小或不存在。
  • 在模拟海拔4,267 m,氨茶碱、安立生坦及联合用药均显著改善亚极量缺氧运动表现(较安慰剂分别提高19.5%、20.6%、19.1%,P<0.05)。
  • 单剂量安立生坦可提高静息缺氧受试者的血氧合,但联合用药改善运动能力不依赖血氧 availability 增加。

核心结论

  • 氨茶碱联合安立生坦可安全提高缺氧人类的运动能力,且不依赖于增加血氧 availability。

研究设计与样本

  • 先在常氧志愿者中建立氨茶碱(500 mg)联合安立生坦(5 mg)的安全性与药物相互作用。
  • 随后采用安慰剂对照研究,在模拟海拔4,267 m的健康静息和运动志愿者中测试联合用药。

主要发现

  • 未发生严重不良事件,药物相互作用极小或不存在。
  • 氨茶碱可缓解缺氧诱导的头痛。
  • 氨茶碱、安立生坦及联合用药均显著改善亚极量缺氧运动表现(P<0.05 vs. 安慰剂),分别较安慰剂提高19.5%、20.6%和19.1%。
  • 单剂量安立生坦增加静息缺氧受试者的血氧合。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We hypothesized that concomitant pharmacological inhibition of the endothelin and adenosine pathway is safe and improves exercise performance in hypoxic humans, via a mechanism that does not involve augmentation of blood oxygenation. To test this hypothesis, we established safety and drug interactions for aminophylline (500 mg) plus ambrisentan (5 mg) in normoxic volunteers. Subsequently, a placebo-controlled study was employed to test the combination in healthy resting and exercising volunteers at simulated altitude (4,267 m). No serious adverse events occurred. Drug interaction was minimal or absent. Aminophylline alleviated hypoxia-induced headaches. Aminophylline, ambrisentan, and their combination all significantly (P < 0.05 vs. placebo) improved submaximal hypoxic exercise performance (19.5, 20.6, and 19.1% >placebo). Single-dose ambrisentan increased blood oxygenation in resting, hypoxic subjects. We conclude that combined aminophylline and ambrisentan offer promise to safely increase exercise capacity in hypoxemic humans without relying on increasing blood oxygen availability.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Schroeder T, Piantadosi CA, Natoli MJ, et al. Safety and Ergogenic Properties of Combined Aminophylline and Ambrisentan in Hypoxia. Clin Pharmacol Ther. 2017. PMID: 28857147. doi:10.1002/cpt.860

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。